The OZY Connection

Published March 28, 2014

The OZY Connection
Filed under: the neuropsychiatry of chronic cocaine abuse
Although Tsai believes that “CI-994 is very promising,” only a clinical trial can reveal whether it works in human patients. It's also not clear how long its effects last. If proven to work in humans, the drug will probably be used alongside therapy … Read more on OZY

Antiretroviral Therapy in 2014: How Does a Doctor Choose?
Filed under: the neuropsychiatry of chronic cocaine abuse
Atripla is an effective medication that has served us well for many years, but the early and usually temporary neuropsychiatric side effects (vivid dreams, dizziness, mood and cognitive changes) have always been a drawback—one that we don't have to … Read more on TheBody.com

Transition Moves Into Late-Stage Drug Development
Filed under: the neuropsychiatry of chronic cocaine abuse
Transition Therapeutics (TTHI) has added late-stage drug development to its operations with its acquisition from Perrigo plc (PRGO) of neuropsychiatric drug candidate, ELND005. "We're maybe a year away from seeing the results of ELND005 in two Phase 2 … Read more on Seeking Alpha